Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Zymergen Inc.
  6. Summary
    ZY   US98985X1000

ZYMERGEN INC.

(ZY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
12.62(c) 11(c) 10.85(c) 10.99(c) 10.45(c) Last
330 056 3 431 713 1 385 456 947 572 1 333 672 Volume
-1.79% -12.84% -1.36% +1.29% -4.91% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 15,5 M - -
Net income 2021 -336 M - -
Net cash position 2021 351 M - -
P/E ratio 2021 -3,50x
Yield 2021 -
Sales 2022 13,5 M - -
Net income 2022 -232 M - -
Net cash position 2022 233 M - -
P/E ratio 2022 -5,81x
Yield 2022 -
Capitalization 1 070 M 1 070 M -
EV / Sales 2021 46,3x
EV / Sales 2022 61,9x
Nbr of Employees 758
Free-Float 91,1%
More Financials
Company
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack... 
Sector
Diversified Chemicals
Calendar
-
More about the company
All news about ZYMERGEN INC.
10/21ZYMERGEN INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or ..
AQ
10/21Zymergen Inc. Announces Stepdown of Jed Dean, Co-Founder, Effective October 31, 2021
CI
10/19Certain Warrants of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-OCT-2..
CI
10/19Certain Stock Options of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-..
CI
10/19Certain Common Stock of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-O..
CI
10/06ZYMERGEN : Shares Fall to Lowest Level Since August Amid Low Trading Volume
MT
10/01ZYMERGEN 72 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swick & Foti,..
BU
10/01ZYMERGEN 24 HOUR DEADLINE ALERT : FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI,..
PR
10/01DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit..
BU
10/01THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the Class Acti..
BU
10/01MONDAY DEADLINE FOR SHAREHOLDERS TO : Bronstein, Gewirtz & Grossman, LLC
BU
09/30KESSLER TOPAZ MELTZER & CHECK, LLP : Important Deadline Reminder for Zymergen Inc. Investo..
BU
09/29SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymer..
PR
09/29Zymergen Inc. Announces the Resignation of Josh Hoffman as Chief Executive Officer
CI
09/29Zymergen Inc. Announces the Resignation of Josh Hoffman as a Board Member
CI
More news
News in other languages on ZYMERGEN INC.
10/06Les actions de Zymergen tombent à leur plus bas niveau depuis août dans un contexte de ..
09/23Zymergen supprime 120 emplois dans le cadre d'un programme de restructuration visant à ..
05/24La recherche de catalyseurs haussiers patine
05/24EN DIRECT DES MARCHES : Airbus, EssilorLuxottica, Solutions 30, Tarkett, Boeing, Coca-Cola..
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 10,45 $
Average target price 10,40 $
Spread / Average Target -0,48%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%1 070
SHIN-ETSU CHEMICAL CO., LTD.6.01%69 894
BASF SE-2.97%67 164
DUPONT DE NEMOURS, INC.1.59%37 786
ROYAL DSM N.V.32.03%36 498
PIDILITE INDUSTRIES LIMITED31.29%15 666